Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
PMV Pharmaceuticals, Inc
Mayo Clinic
STORM Therapeutics LTD
Eli Lilly and Company
Terremoto Biosciences Inc.
Arvinas Inc.
Radiopharm Theranostics, Ltd
Second Life Therapeutics
Tanabe Pharma America, Inc.
Volastra Therapeutics, Inc.
LigaChem Biosciences, Inc.
Bolt Biotherapeutics, Inc.
Incyte Corporation
NuCana plc
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Klus Pharma Inc.
Aminex Therapeutics, Inc.
NextCure, Inc.
Compugen Ltd
Innolake Biopharm
NextCure, Inc.
Incyte Corporation
Incyte Corporation
Seagen Inc.
NKGen Biotech, Inc.
Petra Pharma
Otsuka Novel Products GmbH